Company intelligence / Profile preview

Threotech

City of Industry, California, United Statesthreotech.com ↗

Ownership: Private
Development stage: Other

Overview

Threotech is the exclusive licensee and global marketer of Magtein® (magnesium L-threonate), a branded dietary supplement ingredient with clinical evidence supporting benefits for memory, cognitive function, stress reduction, and sleep. The company holds a strong patent portfolio for Magtein®, has successfully defended its intellectual property in multiple legal disputes, and has achieved commercial success with distribution across major US retailers. Magtein® recently received novel food approval in the EU.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeMineral supplement
Industry: Food & Nutrition

Partnerships

AIDP Inc. (North America distribution)Lsygena (Europe business development/distribution)Avlaan Pharma (India distribution)Dekoba Kimya Ltd Şti. (Turkey/Middle East distributor)

Beyond the preview

Go deeper on Threotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Threotech.

Explore the full profile